Molina Healthcare Inc (NYSE:MOH) has been given an average recommendation of “Hold” by the nineteen brokerages that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $62.23.

MOH has been the subject of several research reports. Zacks Investment Research cut shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Deutsche Bank AG reaffirmed a “hold” rating and set a $72.00 price target on shares of Molina Healthcare in a research note on Wednesday, August 9th. Jefferies Group LLC raised their price target on shares of Molina Healthcare from $60.00 to $64.00 and gave the stock a “hold” rating in a research note on Friday, October 13th. Bank of America Corporation raised their price target on shares of Molina Healthcare from $59.00 to $60.00 and gave the stock an “underperform” rating in a research note on Friday, July 14th. Finally, Morgan Stanley raised shares of Molina Healthcare from an “underweight” rating to an “overweight” rating and raised their price target for the stock from $65.00 to $68.00 in a research note on Thursday, August 17th.

Molina Healthcare (NYSE:MOH) traded up 1.19% during mid-day trading on Thursday, reaching $64.40. 1,136,045 shares of the company’s stock were exchanged. Molina Healthcare has a 52-week low of $42.56 and a 52-week high of $72.79. The stock has a 50-day moving average price of $65.06 and a 200 day moving average price of $63.50. The company’s market cap is $3.68 billion.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.87). The business had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.88 billion. Molina Healthcare had a positive return on equity of 16.10% and a negative net margin of 1.07%. Molina Healthcare’s revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.67 earnings per share. Equities analysts predict that Molina Healthcare will post ($2.31) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Molina Healthcare Inc (MOH) Target Price at $62.23” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/22/brokerages-set-molina-healthcare-inc-moh-target-price-at-62-23.html.

In other Molina Healthcare news, insider William Dentino sold 66,000 shares of the firm’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $60.09, for a total transaction of $3,965,940.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director J Mario Md Molina sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $66.67, for a total value of $1,000,050.00. The disclosure for this sale can be found here. Insiders have sold a total of 390,985 shares of company stock valued at $24,741,496 in the last ninety days. Insiders own 6.20% of the company’s stock.

Institutional investors have recently made changes to their positions in the business. LS Investment Advisors LLC lifted its holdings in Molina Healthcare by 40.9% during the 2nd quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock valued at $127,000 after purchasing an additional 531 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in Molina Healthcare during the 2nd quarter valued at $136,000. Riverhead Capital Management LLC lifted its holdings in Molina Healthcare by 64.2% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after purchasing an additional 963 shares during the last quarter. Sabal Trust CO acquired a new stake in Molina Healthcare during the 3rd quarter valued at $206,000. Finally, Bronfman E.L. Rothschild L.P. lifted its holdings in Molina Healthcare by 478.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock valued at $229,000 after purchasing an additional 2,743 shares during the last quarter. 96.04% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Stock Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related stocks with our FREE daily email newsletter.